Blogs about: Biotechnology Value Fund Activist Investors
Featured Blog
Capstone Therapeutics (NASDAQ:CAPS) position exited
We’ve decided to exit our position in OrthoLogic Corporation (NASDAQ:CAPS) at its $0.90 close yesterday. We opened the position at $0.60, so we’re up 50% on an absolute basis. The S&P5… more →
Greenbackd
Capstone Therapeutics (NASDAQ:CAPS) position exited
wrote 3 years ago: We’ve decided to exit our position in OrthoLogic Corporation (NASDAQ:CAPS) at its $0.90 close … more →
MNOV to acquire AVGN for $1.24 per share; Greenbackd exits
— 1 comment
wrote 3 years ago: MediciNova Inc. (NASDAQ:MNOV) will acquire Avigen Inc (NASDAQ:AVGN) for $1.24 per share in cash or s … more →
Avigen Inc (NASDAQ:AVGN) Q2 10Q update
wrote 3 years ago: Avigen Inc (NASDAQ:AVGN) has filed its 10Q for the period ended June 30, 2009. One interesting aspec … more →
Capstone Therapeutics (NASDAQ:CAPS) Q2 update
wrote 3 years ago: OrthoLogic Corporation (NASDAQ:CAPS) has filed its 10Q for the quarter ended June 30, 2008. We … more →
Avigen granted AV411 patent
— 2 comments
wrote 4 years ago: Avigen Inc (NASDAQ:AVGN) has been granted a United States Patent for the treatment of neuropathic pa … more →
Avigen Inc (NASDAQ:AVGN) Q1 10Q update
wrote 4 years ago: Avigen Inc (NASDAQ:AVGN) has filed its 10Q for the period ended March 31, 2009. We started following … more →
Neurobiological Technologies Inc (NASDAQ:NTII) 10Q update; Greenbackd exits
— 2 comments
wrote 4 years ago: Neurobiological Technologies Inc (NASDAQ:NTII) has filed its 10Q for the period ended march 31, 2009 … more →
List of activist investments for March
wrote 4 years ago: The Official Activist Investing Blog has published its list of activist investments for March (links … more →
NTII on the block; engages financial adviser
wrote 4 years ago: Neurobiological Technologies Inc (NASDAQ:NTII) has engaged a financial adviser to explore a sale of … more →
BVF fails to tip AVGN board
— 1 comment
wrote 4 years ago: Biotechnology Value Fund (BVF) failed in its bid to remove Avigen Inc’s (NASDAQ:AVGN) board at … more →
AVGN ends merger discussions; terminates CEO and other officers
— 3 comments
wrote 4 years ago: Avigen Inc (NASDAQ:AVGN) has discontinued its merger discussions and terminated its Chief Executive … more →
Catalyst Investment Research on AVGN
wrote 4 years ago: Hedge Fund Solutions, which produces The Official Activist Investing Blog, recently announced the la … more →
AVGN to explore settlement with BVF
wrote 4 years ago: Avigen Inc (NASDAQ:AVGN) has authorized its CEO, Dr. Chahine, and RBC to contact Biotechnology Value … more →
Proxy Governance recommends AVGN shareholders support BVF
wrote 4 years ago: Proxy Governance, a proxy advisory firm, has recommended that Avigen Inc (NASDAQ:AVGN) shareholders … more →
AVGN files analysis of MNOV offer
wrote 4 years ago: Avigen Inc (NASDAQ:AVGN) has filed its assessment of the cash portion of the MediciNova Inc (NASDAQ: … more →
BVF increases tender offer for AVGN to $1.20 per share
— 2 comments
wrote 4 years ago: Biotechnology Value Fund (BVF) has increased its tender offer for Avigen Inc (NASDAQ:AVGN) from $1.0 … more →
Empirical Search Strategies supports Biotechnology Value Fund
wrote 4 years ago: Wes Gray’s Empirical Search Strategies (ESS) has proclaimed its support for a “downside … more →
Here, sir, the people govern?
— 5 comments
wrote 4 years ago: We cast our proxy votes on-line today in support of Biotechnology Value Fund’s (BVF) proposal … more →
Glass Lewis say reject BVF proposal; Greenbackd says support BVF proposal
— 2 comments
wrote 4 years ago: Avigen Inc (NASDAQ:AVGN) has sent a letter sent to its stockholders saying that Glass Lewis, a … more →
